Home
About
Overview
Research & Development
Partnerships
Management Team
Board of Directors
Applications
Overview
Animal Applications
Human Applications
Platform
Overview
Algal Biomass
Extract/Supernatant
Bioactive Compounds
Studies/Papers
News & Media
Press Releases
In the News
Project Updates
Presentations
Investors
Overview
News / Events
Company Information
Financial Information
Stock Data
SEC Filings
Corporate Governance
Careers
Contact
All SEC Filings
Investors
Investors
Overview
News / Events
Press Releases
In The News
IR Calendar
Email Alerts
Company Info
Profile
Presentations
Management Team
Contacts
FAQ
Contact
Financial Info
Balance Sheet
Income Statement
Cash Flow
Financial Results
Stock Data
Quote
Charts
Historical Data
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Board of Directors
Governance Documents
Investor Tools
Email Alerts
Tear Sheet
Contacts
RSS News Feed
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
All SEC Filings
Filing Type:
View All
10-K
10-K/A
10-Q
10-Q/A
10KSB
10KSB/A
10QSB
10QSB/A
10SB12G
10SB12G/A
25-NSE
3
3/A
4
4/A
424B3
424B4
424B5
5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
D/A
DEF 14A
DEF 14C
DEFA14A
DEFR14A
EFFECT
NT 10-K
NT 10-K/A
NT 10-Q
NT 10-Q/A
PRE 14A
PREM14C
PRER14A
REGDEX
REGDEX/A
RW
S-1
S-1/A
S-1MEF
S-3
S-8
SB-2
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
UPLOAD
Year:
View All
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
Date
Form
Description
PDF
XBRL
Pages
11/14/17
4
Statement of changes in beneficial ownership of securities
1
11/13/17
8-K
Current report filing
Documents
EX-3.1
4
11/08/17
8-K
Current report filing
Documents
EX-99.1
28
11/02/17
4
Statement of changes in beneficial ownership of securities
1
10/27/17
4
Statement of changes in beneficial ownership of securities
1
10/19/17
10-Q
Quarterly report pursuant to Section 13 or 15(d)
Documents
EX-10.1
EX-31.1
EX-31.2
EX-32.1
EX-32.2
38
10/05/17
4
Statement of changes in beneficial ownership of securities
1
10/03/17
DEF 14A
Definitive proxy statements
23
09/21/17
PRE 14A
Preliminary proxy statement not related to a contested matter or merger/acquisition
24
09/20/17
SC 13D/A
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities
6
25
26
27
28
29
30
31
32
33
34